文献速递主动脉疾病

低剖面与标准剖面覆膜支架治疗胸腹及复杂腹主动脉瘤的多中心队列研究

Low-Profile Versus Standard-Profile Endograft for Thoracoabdominal and Complex Abdominal Endovascular Aortic Treatment-Multicenter Cohort Study.
PubMed 文献 · J Endovasc Ther · 2026-10-08

多中心回顾性队列研究纳入478例接受开窗/分支腔内修复(FB-EVAR)的胸腹主动脉瘤(TAAA)和复杂腹主动脉瘤(CAAA)患者,比较低剖面支架(LPSG)与标准剖面支架(SPSG)的结局。结果显示两组技术成功率、术后并发症、总生存率及免于再干预率均相似,LPSG更多用于既往主动脉手术及困难入路等复杂病例。

要点

  • LPSG与SPSG的技术成功率相似(92.7% vs 95.0%,P=.33)。
  • 两组总生存(HR 1.06,95%CI 0.66-1.71)与免于再干预(HR 1.04,95%CI 0.64-1.70)无显著差异。
  • LPSG更常用于既往主动脉手术(44.9% vs 33.6%,P=.022)及中重度髂动脉钙化(29.9% vs 18.3%,P=.006)患者。

核心结论

  • LPSG与SPSG在FB-EVAR治疗TAAA和CAAA中具有相似的技术成功率和死亡率。
  • LPSG更多用于既往主动脉修复和困难入路的复杂病例,早中期结局与SPSG相当。

研究设计与样本

  • 多中心回顾性队列研究,连续纳入接受FB-EVAR治疗TAAA和CAAA的患者。
  • 共478例患者,平均年龄71.6岁(±8.96),男性占80.3%;TAAA 227例,CAAA 251例。
  • LPSG组137例(28.7%),SPSG组341例(71.3%)。

主要发现

  • LPSG组与SPSG组技术成功率分别为92.7%和95.0%(P=.33)。
  • 术后并发症无显著差异;持续性或晚期内漏无统计学差异(P=.36)。
  • 总生存HR 1.06(95%CI 0.66-1.71,P=.78),免于再干预HR 1.04(95%CI 0.64-1.70,P=.86)。
  • LPSG组既往主动脉手术比例44.9% vs 33.6%(P=.022),中重度髂动脉钙化29.9% vs 18.3%(P=.006),迂曲指数1.35±0.23 vs 1.29±0.16(P=.030)。
  • 每例患者目标血管中位数均为4(LPSG IQR 4-4,SPSG IQR 3-4,P<.001)。

临床怎么用

  • 在既往主动脉修复或髂动脉钙化等困难入路病例中,LPSG可作为SPSG的可行替代选择。
  • LPSG与SPSG早中期安全性和有效性相似,选择可基于解剖条件和器械可及性。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • 中位随访时间仅6.9个月(IQR 0.8-28.7),缺乏长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The introduction of low-profile stent grafts (LPSGs) has proven to be a useful option despite initial concerns. The aim of this study was to analyze and compare the outcomes of standard-profile stent grafts (SPSGs) versus LPSG in a cohort of patients treated for thoracoabdominal (TAAA) and complex abdominal (CAAA) aortic aneurysms. METHODS: A multi-center cohort study based on a retrospective analysis of consecutive patients admitted for the treatment of TAAA and CAAA using fenestrated and/or branched endovascular aneurysm repair (FB-EVAR) was performed. Outcomes were compared in patients treated with LPSG versus SPSG including procedural metrics, technical success (TS), clinical complications, access-related complications, overall survival, stent-graft integrity issues, secondary interventions, sac enlargement, and primary patency of target vessels (TVs). RESULTS: A total of 478 patients were included, with a mean age of 71.6 years (±8.96), and 80.3% were male. There were 227 TAAAs and 251 CAAAs, with a median of 4 (interquartile range [IQR]: 4-4) vessels catheterized per patient. Low-profile stent grafts were used in 137 (28.7%) patients and SPSGs in 341 (71.3%) patients. Low-profile stent grafts were more frequently used in patients with previous aortic surgery (44.9% vs 33.6%, P = .022), and the number of TVs treated differed significantly between LPSG and SPSG (4, IQR: 4-4 vs 4, IQR: 3-4; P < .001). Moderate-to-severe iliac calcification was significantly more common in the LPSG group (29.9% [n = 40] vs 18.3% [n = 61], P = .006). The tortuosity index was also higher in the LPSG group (1.35 ± 0.23) compared with in the SPSG group (1.29 ± 0.16, P = .030). Patients treated with LPSG had a similar TS rate (92.7% vs 95.0%, P = .33). There were no significant differences in postoperative complications. The median follow-up period was 6.9 months (IQR: 0.8-28.7). Regarding persistent or late endoleaks, no statistically significant differences were observed (P = .36). Overall survival (hazard ratio [HR]: 1.06; 95% CI, 0.66-1.71; P = .78) and freedom from reintervention (HR: 1.04; 95% CI, 0.64-1.70; P = .86) were also similar between groups. CONCLUSION: Fenestrated and/or branched endovascular aneurysm repair with LPSG and SPSG was performed with similar rates of TS and mortality. Low-profile stent grafts were more often used in complex cases with prior aortic repairs and challenging access. Early and mid-term outcomes were comparable, with both devices showing similar safety and effectiveness profiles.Clinical ImpactWe performed a retrospective, multicenter cohort study including 478 patients, comparing low-profile stent grafts with standard-profile grafts in the treatment of complex aortic aneurysms. Both types of stent grafts demonstrated similar technical success, safety, and effectiveness. Low-profile endografts proved to be a viable option, particularly in more challenging cases.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Magalhães T, Gouveia E Melo R, Stana J, et al. Low-Profile Versus Standard-Profile Endograft for Thoracoabdominal and Complex Abdominal Endovascular Aortic Treatment-Multicenter Cohort Study. J Endovasc Ther. 2026. PMID: 42847199. doi:10.1177/15266028261489194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。